ATAI vs TDG · rev $4.1M vs P/E 41, rev $8.83B
ATAI Life Sciences BV (ATAI) versus Transdigm Group Incorporated (TDG) — a side-by-side from cached financials, not a winner call.
ATAI Life Sciences BV (ATAI) is a biotechnology company listed on US.
Transdigm Group Incorporated (TDG) is a aerospace & defense company listed on NYSE.
Latest reported ATAI revenue for 2025-12-31 was $4.1M. Net income was -$660.0M. Revenue was up 1227.6% from 2024-12-31 to 2025-12-31. ATAI currently screens at market cap $555.8M.
Latest reported TDG revenue for 2025-09-30 was $8.83B. Net income was $2.07B. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
ATAI currently screens at market cap $555.8M. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
Not investment advice. Open the ATAI and TDG stock pages for the full models.
Not investment advice.